Vident Advisory’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,144
Closed -$17.7K 1626
2025
Q1
$17.7K Sell
12,144
-8,823
-42% -$17.2K ﹤0.01% 1552
2024
Q4
$32.1K Sell
20,967
-2,134
-9% -$3.47K ﹤0.01% 1430
2024
Q3
$41.8K Sell
23,101
-2,195
-9% -$4.01K ﹤0.01% 1403
2024
Q2
$42.5K Sell
25,296
-3,362
-12% -$7K ﹤0.01% 1393
2024
Q1
$73.9K Sell
28,658
-1,419
-5% -$3.31K ﹤0.01% 1297
2023
Q4
$59.5K Sell
30,077
-13,415
-31% -$11.7K ﹤0.01% 1295
2023
Q3
$40.4K Buy
+43,492
New +$47.8K ﹤0.01% 1238

Other funds holding CGEN

Vident Advisory's CGEN Position: Q2 2025 in Review

Vident Advisory sold out of Compugen (CGEN) in Q2 2025, closing a stake of 12,144 shares — an estimated $17.7K sold.

Vident Advisory first reported a position in CGEN in Q3 2023 and held it in 7 quarters. The position peaked at $73.9K in Q1 2024. 70 funds tracked by Wall St. Rank hold CGEN as of Q2 2025.

  • Vident Advisory reported no remaining Compugen position as of Q2 2025 after selling out during the quarter.
  • Vident Advisory sold 12,144 Compugen shares in Q2 2025, an estimated $17.7K.
  • Vident Advisory first reported a position in Compugen in Q3 2023 and held it in 7 quarters.
  • Vident Advisory's Compugen position peaked at $73.9K in Q1 2024.
  • 70 funds tracked by Wall St. Rank held Compugen as of Q2 2025.

Based on Vident Advisory's 13F filing for Q2 2025, filed 14 Aug 2025.